Staff Publications: December 2018

  1. Al-Hebshi NN, Nasher AT, Maryoud MY, et al. Inflammatory Bacteriome Featuring Fusobacterium Nucleatum and Pseudomonas Aeruginosa Identified in Association with Oral Squamous Cell Carcinoma. Sci Rep. 2017;7(1):1834. PMID: 28500338. PMC5431832.
  2. Bai T, Chanda AK, Egleston BL, Vucetic S. EHR Phenotyping via Jointly Embedding Medical Concepts and Words into a Unified Vector Space. BMC Med Inform Decis Mak. 2018;18(Suppl 4):123. PMID: 30537974. PMC6290514.
  3. Bair SM, Strelec LE, Feldman TA, et al. Outcomes and Toxicities of Programmed Death-1 (PD-1) Inhibitors in Hodgkin Lymphoma Patients in the United States: A Real-World, Multicenter Retrospective Analysis. Oncologist. 2018. PMID: 30568021.
  4. Bergman A, Gligorijevic B. Real-Time Imaging of Invadopodia in Tumor Microenvironment Context. (2018) Optics InfoBase Conference Papers, Part F89-MICROSCOPY 2 p.
  5. Cheson BD, O’Brien S, Ewer MS, et al. Optimal Management of Adverse Events from Copanlisib in the Treatment of Patients with Non-Hodgkin Lymphomas. Clin Lymphoma Myeloma Leuk. 2018. PMID: 30584024.
  6. Correa AF, Yankey H, Li T, et al. Renal Hilar Lesions: Biological Implications for Complex Partial Nephrectomy. Urology. 2019;123:174-180. PMID: 30296503.
  7. de Prisco N, Stout E, Font-Burgada J. Specific Labeling and Lineage Tracing of Periportal Hepatocytes Using Two-Step Genetic Recombination. Methods Mol Biol. 2019;1905:59-70. PMID: 30536090.
  8. Dignam JJ, Hamstra DA, Lepor H, et al. Time Interval to Biochemical Failure as a Surrogate End Point in Locally Advanced Prostate Cancer: Analysis of Randomized Trial NRG/RTOG 9202. J Clin Oncol. 2018:JCO1800154. PMID: 30526194.
  9. Dyer KE, Shires DA, Flocke SA, et al. Patient-Reported Needs Following a Referral for Colorectal Cancer Screening. Am J Prev Med. 2018. PMID: 30554975.
  10. Edwards DC, Cahn DB, Reddy M, et al. Incisional Hernia after Cystectomy: Incidence, Risk Factors and Anthropometric Predisposition. Can J Urol. 2018;25(6):9573-9578. PMID: 30553281.
  11. Ghatalia P, Zibelman MR, Geynisman DM, Plimack ER. Evolving Landscape of the Treatment of Metastatic Clear Cell Renal Cell Carcinoma. Clin Adv Hematol Oncol. 2018;16(10):677-686. PMID: 30543598.
  12. Gotlib J, Gerds AT, Bose P, et al. Systemic Mastocytosis, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2018;16(12):1500-1537. PMID: 30545997.
  13. Gounder MM, Mahoney MR, Van Tine BA, et al. Sorafenib for Advanced and Refractory Desmoid Tumors. N Engl J Med. 2018;379(25):2417-2428. PMID: 30575484.
  14. Graves KD, Hall MJ, Tercyak KP. Introduction to the Special Issue on Clinical and Public Health Genomics: Opportunities for Translational Behavioral Medicine Research, Practice, and Policy. Transl Behav Med. 2018;8(1):4-6. PMID: 29385593. PMC6065537.
  15. Haddad RI, Nasr C, Bischoff L, et al. NCCN Guidelines Insights: Thyroid Carcinoma, Version 2.2018. J Natl Compr Canc Netw. 2018;16(12):1429-1440. PMID: 30545990.
  16. Hendifar AE, Petzel MQB, Zimmers TA, et al. Pancreas Cancer-Associated Weight Loss. Oncologist. 2018. PMID: 30591550.
  17. Hernandez Borrero LJ, Sikder R, Lulla A, et al. Bcl-2 Protein Targeting by the P53/P21 Complex-Letter. Cancer Res. 2018;78(10):2770-2771. PMID: 29703721.
  18. Heyza JR, Arora S, Zhang H, et al. Targeting the DNA Repair Endonuclease ERCC1-XPF with Green Tea Polyphenol Epigallocatechin-3-Gallate (EGCG) and Its Prodrug to Enhance Cisplatin Efficacy in Human Cancer Cells. Nutrients. 2018;10(11). PMID: 30400270. PMC6267282.
  19. Ito T, Derweesh IH, Ginzburg S, et al. Perioperative Outcomes Following Partial Nephrectomy Performed on Patients Remaining on Antiplatelet Therapy. J Urol. 2017;197(1):31-36. PMID: 27418453.
  20. Jones CE, Hammer AM, Cho Y, et al. Stromal PTEN Regulates Extracellular Matrix Organization in the Mammary Gland. Neoplasia. 2019;21(1):132-145. PMID: 30550871. PMC6293034.
  21. Kasagi Y, Dods K, Wang JX, et al. Fibrostenotic Eosinophilic Esophagitis May Reflect Epithelial Lysyl Oxidase Induction by Fibroblasts-Derived Tumor Necrosis Factor-Alpha. J Allergy Clin Immunol. 2018. PMID: 30578874.
  22. Kluetz PG, Kanapuru B, Lemery S, et al. Informing the Tolerability of Cancer Treatments Using Patient-Reported Outcome Measures: Summary of an Fda and Critical Path Institute Workshop. Value Health. 2018;21(6):742-747. PMID: 29909880.
  23. Kozlova AL, Valieva ME, Maluchenko NV, Studitsky VM. HMGB Proteins as DNA Chaperones That Modulate Chromatin Activity. Molecular Biology. 2018;52(5):637-647.
  24. Liao L, Alicea-Velazquez NL, Langbein L, et al. High Affinity Binding of H3K14AC through Collaboration of Bromodomains 2, 4, and 5 is Critical for the Molecular and Tumor Suppressor Functions of PBRM1. Mol Oncol. 2018. PMID: 30585695.
  25. Lin T, Hossain M, Fan J, Ma CC. When and How to Treat an IMRT Patient on a Second Accelerator without Replanning? Med Dosim. 2018;43(4):334-343. PMID: 29287919.
  26. Liu B, Tang L, Zhang X, et al. A Cell-Based High Throughput Screening Assay for the Discovery of CGAS-STING Pathway Agonists. Antiviral Res. 2017;147:37-46. PMID: 28982551. PMC5789800. NIHMS911402.
  27. Lu H, Liu S, Zhang G, et al. Author Correction: PAK Signalling Drives Acquired Drug Resistance to MAPK Inhibitors in BRAF-Mutant Melanomas. Nature. 2019;565(7738):E4. PMID: 30532003.
  28. MacFawn I, Wilson H, Selth LA, et al. Grainyhead-Like-2 Confers NK-Sensitivity through Interactions with Epigenetic Modifiers. Mol Immunol. 2018;105:137-149. PMID: 30508726.
  29. Magnius L, Taylor J, Mason WS, et al. ICTV Virus Taxonomy Profile: Deltavirus. J Gen Virol. 2018;99(12):1565-1566. PMID: 30311870.
  30. Martin JM, Wu H, Barta SK. Cd30+ T-Cell Lymphoproliferative Disorders. Chin Clin Oncol. 2018. PMID: 30525751.
  31. Mavaddat N, Michailidou K, Dennis J, et al. Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes. Am J Hum Genet. 2019;104(1):21-34. PMID: 30554720.
  32. Ming M, Wu W, Xie B, et al. XPO1 Inhibitor Selinexor Overcomes Intrinsic Ibrutinib Resistance in Mantle Cell Lymphoma via Nuclear Retention of IκB. Mol Cancer Ther. 2018;17(12):2564-2574. PMID: 3051014.
  33. Mortazavi SAR, Kadivar F, Mortazavi SMJ. Comments on, “A Narrative Review of Interventions for Improving Sleep and Reducing Circadian Disruption in Medical Inpatients”. Sleep Med. 2018. PMID: 30503687.
  34. Parham LR, Williams PA, Chatterji P, Whelan KA, Hamilton KE. RNA Regulons Are Essential in Intestinal Homeostasis. Am J Physiol Gastrointest Liver Physiol. 2019;316(1):G197-G204. PMID: 30520692.
  35. Pourfarhangi KE, Bayarmagnai B, de la Hoz EC, Cohen A, Gligorijevic B. A Methodology to Investigate the Relationship between Cancer Cells Cell-Cycle Phase and Their Migratory Behaviors. Optics InfoBase Conference Papers, Part F91-TRANSLATIONAL. 2 p. 2018.
  36. Prabhu VV, Madhukar NS, Gilvary C, et al. Dopamine Receptor D5 is a Modulator of Tumor Response to Dopamine Receptor D2 Antagonism. Clin Cancer Res. 2018. PMID: 30559168.
  37. Ramos JD, Wingate JT, Gulati R, et al. Venous Thromboembolism Risk in Patients with Locoregional Urothelial Tract Tumors. Clin Genitourin Cancer. 2017;16(1):e161-e167. PMID: 28923700. PMC5826750.
  38. Redner RL, Beumer JH, Kropf P, et al. A Phase-1 Study of Dasatinib plus All-Trans Retinoic Acid in Acute Myeloid Leukemia. Leuk Lymphoma. 2018;59(11):2595-2601. PMID: 29616864. PMC6201295.
  39. Reese JB, Smith KC, Handorf E, et al. A Randomized Pilot Trial of a Couple-Based Intervention Addressing Sexual Concerns for Breast Cancer Survivors. J Psychosoc Oncol. 2018:1-22. PMID: 30580675.
  40. Reese JB, Sorice KA, Oppenheimer NM, et al. Why Do Breast Cancer Survivors Decline a Couple-Based Intimacy Enhancement Intervention Trial? Transl Behav Med. 2018. PMID: 30544201.
  41. Roethke SK, Ryan JC, Wood SY. Management of Older Patients with Metastatic Renal Cell Carcinoma Receiving Sunitinib: A Hypothetical, Illustrative Case Scenario. J Adv Pract Oncol. 2018;9(1):67-76. PMID: 30564469. PMC6296420.
  42. Roussi P, Miller SM, Giri VN, et al. Effects of a Randomized Trial Comparing Standard and Enhanced Counseling for Men at High Risk of Prostate Cancer as a Function of Race and Monitoring Style. J Health Psychol. 2016;23(14):1359105316671188. PMID: 28810355. PMC5561513.
  43. Shulman RM, Meyer JE, Li T, Howell KJ. External Beam Radiation Therapy (EBRT) for Asymptomatic Bone Metastases in Patients with Solid Tumors Reduces the Risk of Skeletal-Related Events (SRES). Ann Palliat Med. 2018. PMID: 30525770.
  44. Su Y, Hopfinger NR, Nguyen TD, Pogash TJ, Santucci-Pereira J, Russo J. Epigenetic Reprogramming of Epithelial Mesenchymal Transition in Triple Negative Breast Cancer Cells with DNA Methyltransferase and Histone Deacetylase Inhibitors. J Exp Clin Cancer Res. 2018;37(1):314. PMID: 30547810. PMC6295063.
  45. Walpole S, Pritchard AL, Cebulla CM, et al. Comprehensive Study of the Clinical Phenotype of Germline BAP1 Variant-Carrying Families Worldwide. J Natl Cancer Inst. 2018;110(12):1328-1341. PMID: 30517737. PMC6292796.
  46. White MN, Dotan E, Catalano PJ, Cardin DB, Berlin JD. Advanced Pancreatic Cancer Clinical Trials: The Continued Underrepresentation of Older Patients. J Geriatr Oncol. 2018. PMID: 30573201.
  47. Wickersham KE, Hodges TK, Edelman MJ, Song Y, Nan M, Dorsey SG. Differential Gene Expression in Erlotinib-Treated Fibroblasts. Nurs Res. 2018. PMID: 30540703.
  48. Winer A, Adams S, Mignatti P. Matrix Metalloproteinase Inhibitors in Cancer Therapy: Turning Past Failures into Future Successes. Mol Cancer Ther. 2018;17(6):1147-1155. PMID: 29735645. PMC5984693.
  49. Zaorsky NG, Lehrer EJ, Handorf E, Meyer JE. Dose Escalation in Stereotactic Body Radiation Therapy for Pancreatic Cancer: A Meta-Analysis. Am J Clin Oncol. 2019;42(1):46-55. PMID: 29965809.

Holiday Hours-2018

Talbot Library will be closed on Monday, December 24th and Tuesday, December 25th. Regular hours will resume on Wednesday, December 26th. We will be closed on Tuesday, January 1, 2019. Regular hours will resume on Wednesday, January 2nd.

Thank you and we look forward to collaborating with you in the new year.

Staff Publications: November 2018

  1. Abbas AE. Surgical Management of Lung Cancer: History, Evolution, and Modern Advances. Curr Oncol Rep. 2018;20(12):98. PMID: 30421260.
  2. Abboud CN, Lang N, Fung H, et al. Real-World Safety Experience of Tevagrastim/Ratiograstim/Biograstim and Tbo-Filgrastim, Short-Acting Recombinant Human Granulocyte Colony-Stimulating Factors. Support Care Cancer. 2018. PMID: 30443809.
  3. Ablain J, Xu M, Rothschild H, et al. Human Tumor Genomics and Zebrafish Modeling Identify SPRED1 Loss as a Driver of Mucosal Melanoma. Science. 2018;362(6418):1055-1060. PMID: 30385465.
  4. Anari F, O’Neill J, Choi W, et al. Neoadjuvant Dose-Dense Gemcitabine and Cisplatin in Muscle-Invasive Bladder Cancer: Results of a Phase 2 Trial. Eur Urol Oncol. 2018;1(1):54-60. PMID: 30420974. PMC6226048. NIHMS966051
  5. Andersen MR, Karlan BY, Drescher CW, et al. False-Positive Screening Events and Worry Influence Decisions About Surgery among High-Risk Women. Health Psychol. 2018. PMID: 30431292.
  6. Andres SF, Williams KN, Plesset JB, et al. IMP1 3′ UTR Shortening Enhances Metastatic Burden in Colorectal Cancer. Carcinogenesis. 2018. PMID: 30407516.
  7. Asghar AM, McIntosh AG, Kutikov A, Chen DY, Geynisman DM. Neoadjuvant Chemotherapy for Penile Cancer Enabling Organ Preservation: A Case of Individualized Management for Bilateral Lymph Node Metastasis and a Bulky Primary Tumor. Urol Case Rep. 2019;23:3-5. PMID: 30505684. PMC6260424.
  8. Banerjee PP, Pang L, Soldan SS, et al. KIR2DL4-HLAG Interaction at Human NK Cell-Oligodendrocyte Interfaces Regulates IFN-γ-Mediated Effects. Mol Immunol. 2018. PMID: 30482463.
  9. Beitler JJ, Ridge JA, Vermorken JB, et al. T4 Laryngeal Cancer with Good Function: Should We Be Reluctant to Treat without Surgery? International Journal of Radiation Oncology Biology Physics. 2018;102(5):1400-1403.
  10. Beri N, Patrick-Miller LJ, Egleston BL, et al. Preferences for in-Person Disclosure: Patients Declining Telephone Disclosure Characteristics and Outcomes in the Multicenter Communication of Genetic Test Results by Telephone Study. Clin Genet. 2018. PMID: 30417332.
  11. Bevelacqua JJ, Mortazavi SMJ. Comments on “Irradiation Effects of MeV Protons on Dry and Hydrated Brassica rapa Seeds”. Life Sci Space Res (Amst). 2018;19:51. PMID: 30482281.
  12. Bevers TB, Helvie M, Bonaccio E, et al. Breast Cancer Screening and Diagnosis, Version 3.2018, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2018;16(11):1362-1389. PMID: 30442736.
  13. Blackman E, Ashing K, Gibbs D, et al. The Cancer Prevention Project of Philadelphia: Preliminary Findings Examining Diversity among the African Diaspora. Ethn Health. 2018:1-17. PMID: 30453751.
  14. Bleicher RJ, Chang C, Wang CE, et al. Treatment Delays from Transfers of Care and Their Impact on Breast Cancer Quality Measures. Breast Cancer Res Treat. 2018. PMID: 30443881.
  15. Bruinooge SS, Pickard TA, Vogel W, et al. Understanding the Role of Advanced Practice Providers in Oncology in the United States. Jaapa. 2018;31(12):1-12. PMID: 30489397.
  16. Campbell KS, Cohen AD, Pazina T. Mechanisms of NK Cell Activation and Clinical Activity of the Therapeutic SLAMF7 Antibody, Elotuzumab in Multiple Myeloma. Front Immunol. 2018;9:2551. PMID: 30455698. PMC6230619. .
  17. Capo-Chichi CD, Cai KQ, Xu XX. Overexpression and Cytoplasmic Localization of caspase-6 Is Associated with Lamin a Degradation in Set of Ovarian Cancers. Biomark Res. 2018;6:30. PMID: 30450209. PMC6208109.
  18. Chang HW, Valieva ME, Safina A, et al. Mechanism of Fact Removal from Transcribed Genes by Anticancer Drugs Curaxins. Sci Adv. 2018;4(11):eaav2131. PMID: 30417101. PMC6221510.
  19. Chien CR, Geynisman DM, Kim B, Xu Y, Shih YT. Economic Burden of Renal Cell Carcinoma-Part I: An Updated Review. Pharmacoeconomics. 2018. PMID: 30467701.
  20. Churilla TM, Chowdhury IH, Handorf E, et al. Comparison of Local Control of Brain Metastases with Stereotactic Radiosurgery vs Surgical Resection: A Secondary Analysis of a Randomized Clinical Trial. JAMA Oncol. 2018. PMID: 30419088.
  21. Clark S, Ebersole B. Understanding the Role of Speech Language Pathologists in Managing Dysphagia. Nursing. 2018;48(12):42-46. PMID: 30461710.
  22. Collins ME, Abrahm JL. Communication Challenges at the Crossroads of Oncology and Palliative Care: Finding a Way Forward When Clinicians Differ on Prognosis. J Palliat Care. 2018:825859718814767. PMID: 30484363.
  23. Correa AF, Uzzo RG. Author Response. Urology. 2018.
  24. D’Avella C, Abbosh P, Pal SK, Geynisman DM. Mutations in Renal Cell Carcinoma. Urol Oncol. 2018. PMID: 30478013.
  25. Del Bene G, Calabro F, Giannarelli D, et al. Neoadjuvant vs. Adjuvant Chemotherapy in Muscle Invasive Bladder Cancer (MIBC): Analysis from the RISC Database. Front Oncol. 2018;8:463. PMID: 30510914. PMC6252384.
  26. Drilon A, Fu S, Patel MR, et al. A Phase I/Ib Trial of the VEGFR-Sparing Multikinase RET Inhibitor RXDX-105. Cancer Discov. 2018. PMID: 30487236.
  27. Edwards DC, Cahn DB, Smaldone MC, Kutikov A. Use of Administrative Data for Comparative Effectiveness Research in the Treatment of Non-Prostate Genitourinary Malignancies. Urol Oncol. 2018;36(4):193-212. PMID: 28867432.
  28. Fatkhullina AR, Peshkova IO, Dzutsev A, et al. An Interleukin-23-Interleukin-22 Axis Regulates Intestinal Microbial Homeostasis to Protect from Diet-Induced Atherosclerosis. Immunity. 2018;49(5):943-957 e949. PMID: 30389414. PMC6257980. NIHMS1510832.
  29. Gasoyan H, Tajeu G, Halpern MT, Sarwer DB. Reasons for Underutilization of Bariatric Surgery: The Role of Insurance Benefit Design. Surg Obes Relat Dis. 2018. PMID: 30425002.
  30. Gillison ML, Trotti AM, Harris J, et al. Radiotherapy Plus Cetuximab or Cisplatin in Human Papillomavirus-Positive Oropharyngeal Cancer (Nrg Oncology Rtog 1016): A Randomised, Multicentre, Non-Inferiority Trial. Lancet. 2018. PMID: 30449625.
  31. Hanada Y, Choi AY, Hwang JH, et al. Low Frequency of Lymph Node Metastases in Patients in the United States with Early-Stage Gastric Cancers That Fulfill Japanese Endoscopic Resection Criteria. Clin Gastroenterol Hepatol. 2018. PMID: 30471457.
  32. Handra-Luca A, Wei S. Intrathyroid Cystic Thyroglossal Duct Remnant and Ectopic Thymus: A Fortuitous or Development-Related Association? Surg Today. 2018;48(8):815-818. PMID: 29460127.
  33. Holschneider CH, Petereit DG, Chu C, et al. Brachytherapy: A Critical Component of Primary Radiation Therapy for Cervical Cancer: For the Society of Gynecologic Oncology (SGO) and the American Brachytherapy Society (ABS). Gynecol Oncol. 2018.
  34. Hopper JL, Dite GS, MacInnis RJ, et al. Age-Specific Breast Cancer Risk by Body Mass Index and Familial Risk: Prospective Family Study Cohort (Prof-Sc). Breast Cancer Res. 2018;20(1):132. PMID: 30390716. PMC6215632.
  35. Horwitz EM, Ridge JA, Bruner DW, Movsas B, Pollack A, Fowble B. Gerald E. Hanks, Md, Fastro Obituary. International Journal of Radiation Oncology Biology Physics. 2018;102(5):1393-1395.
  36. Hulse M, Caruso LB, Madzo J, Tan Y, Johnson S, Tempera I. Poly(ADP-Ribose) Polymerase 1 Is Necessary for Coactivating Hypoxia-Inducible Factor-1-Dependent Gene Expression by Epstein-Barr Virus Latent Membrane Protein 1. PLoS Pathog. 2018;14(11):e1007394. PMID: 30395643. PMC6237423.
  37. Ismail HM, Krishnamoorthy N, Al-Dewik N, et al. In Silico and in Vivo Models for Qatari-Specific Classical Homocystinuria as Basis for Development of Novel Therapies. Hum Mutat. 2018. PMID: 30408270.
  38. Karchugina S, Chernoff J. Detection of Heterodimerization of Protein Isoforms Using an in Situ Proximity Ligation Assay. J Vis Exp. 2018(140). PMID: 30394375. PMC6235567.
  39. Kijima T, Nakagawa H, Shimonosono M, et al. Three-Dimensional Organoids Reveal Therapy Resistance of Esophageal and Oropharyngeal Squamous Cell Carcinoma Cells. Cell Mol Gastroenterol Hepatol. 2019;7(1):73-91. PMID: 30510992. PMC6260338.
  40. Klingler MJ, Babitz SK, Kutikov A, et al. Assessment of Volume Preservation Performed before or after Partial Nephrectomy Accurately Predicts Postoperative Renal Function: Results from a Prospective Multicenter Study. Urol Oncol. 2018. PMID: 30473205.
  41. Liu JC, Bhayani M, Kuchta K, Galloway T, Fundakowski C. Patterns of Distant Metastasis in Head and Neck Cancer at Presentation: Implications for Initial Evaluation. Oral Oncology. 2019;88:131-136.
  42. Malik R, Luong T, Cao X, et al. Rigidity Controls Human Desmoplastic Matrix Anisotropy to Enable Pancreatic Cancer Cell Spread Via Extracellular Signal-Regulated Kinase 2. Matrix Biol. 2018. PMID: 30412725.
  43. Manley C, Olszanski A. Melanoma in the Bronchus. N Engl J Med. 2018;379(20):e36. PMID: 30428282.
  44. Masic S, Kutikov A. Robotic Inferior Vena Cava Thrombectomy: Are We Entering the House through an Attic Window? Eur Urol Focus. 2018. PMID: 30415922.
  45. Matulonis UA, Birrer MJ, O’Malley DM, et al. Evaluation of Prophylactic Corticosteroid Eye Drop Use in the Management of Corneal Abnormalities Induced by the Antibody-Drug Conjugate Mirvetuximab Soravtansine. Clin Cancer Res. 2018. PMID: 30413525.
  46. Mortazavi SMJ. Re: Presence of Multidrug Resistant Bacteria on Mobile Phones of Healthcare Workers Accelerates the Spread of Nosocomial Infections and Regarded as a Threat to Public Health in Bangladesh. J Microsc Ultrastruct. 2018;6(4):215-216. PMID: 30464896. PMC6206753.
  47. Pei J, Al-Saleem T, Uzzo RG, Dulaimi E, Testa JR, Wei S. Application of Chromosome Microarray Analysis for the Differential Diagnosis of Low-Grade Renal Cell Carcinoma with Clear Cell and Papillary Features. Appl Immunohistochem Mol Morphol. 2018. PMID: 30499818.
  48. Ragin C, Banydeen R, Zhang C, et al. Breast Cancer Research in the Caribbean: Analysis of Reports from 1975 to 2017. J Glob Oncol. 2018(4):1-21. PMID: 30481085.
  49. Roach M, Moughan J, Lawton CAF, et al. Sequence of Hormonal Therapy and Radiotherapy Field Size in Unfavourable, Localised Prostate Cancer (NRG/RTOG 9413): Long-Term Results of a Randomised, Phase 3 Trial. Lancet Oncol. 2018;19(11):1504-1515. PMID: 30316827.
  50. Rogers HL, Dumenci L, Epstein RM, Siminoff LA. Impact of Patient Gender and Race and Physician Communication on Colorectal Cancer Diagnostic Visits in Primary Care. J Womens Health (Larchmt). 2018. PMID: 30489201.
  51. Shafi AA, Schiewer MJ, de Leeuw R, et al. Patient-Derived Models Reveal Impact of the Tumor Microenvironment on Therapeutic Response. Eur Urol Oncol. 2018;1(4):325-337. PMID: 30467556. PMC6241309. NIHMS972310.
  52. Streiff MB, Holmstrom B, Angelini D, et al. Nccn Guidelines Insights: Cancer-Associated Venous Thromboembolic Disease, Version 2.2018. J Natl Compr Canc Netw. 2018;16(11):1289-1303. PMID: 30442731.
  53. Terry MB, Daly MB, Phillips KA, et al. Risk-Reducing Oophorectomy and Breast Cancer Risk across the Spectrum of Familial Risk. J Natl Cancer Inst. 2018. PMID: 30496449.
  54. Tomalka AG, Resto-Garay I, Campbell KS, Popkin DL. In Vitro Evidence That Combination Therapy with CD16-Bearing NK-92 Cells and FDA-Approved Alefacept Can Selectively Target the Latent HIV Reservoir in CD4+ CD2HI Memory T Cells. Front Immunol. 2018;9:2552. PMID: 30455699. PMC6230627.
  55. Tripathi A, Plimack ER. Immunotherapy for Urothelial Carcinoma: Current Evidence and Future Directions. Curr Urol Rep. 2018;19(12):109. PMID: 30406502.
  56. Vrakas CN, Herman AB, Ray M, Kelemen SE, Scalia R, Autieri MV. Rna Stability Protein ILF3 Mediates Cytokine-Induced Angiogenesis. FASEB J. 2018:fj201801315R. PMID: 30383449.
  57. Zhang H, Pandey S, Travers M, et al. Targeting Cdk9 Reactivates Epigenetically Silenced Genes in Cancer. Cell. 2018;175(5):1244-1258 e1226. PMID: 30454645. PMC6247954. NIHMS1510720.

Read More »

Staff Publications: October 2018

  1. Amin A, Plimack ER, Ernstoff MS, et al. Safety and Efficacy of Nivolumab in Combination with Sunitinib or Pazopanib in Advanced or Metastatic Renal Cell Carcinoma: The Checkmate 016 Study. J Immunother Cancer. 2018;6(1):109. PMID: 30348216. PMC6196426.
  2. Arora S, Heyza JR, Chalfin EC, Ruch RJ, Patrick SM. Gap Junction Intercellular Communication Positively Regulates Cisplatin Toxicity by Inducing DNA Damage through Bystander Signaling. Cancers (Basel). 2018;10(10). PMID: 30279363. PMC6210410.
  3. Badar T, Hamadani M, Bachanova V, et al. Efficacy of Salvage Chemotherapy in Diffuse Large B Cell Lymphoma with Primary Treatment Failure According to Putative Cell of Origin. Leuk Lymphoma. 2018:1-7. PMID: 30277110.
  4. Barone FC, Marcinkiewicz C, Li J, et al. Pilot Study on Biocompatibility of Fluorescent Nanodiamond-(NV)-Z~800 Particles in Rats: Safety, Pharmacokinetics, and Bio-Distribution (Part III). Int J Nanomedicine. 2018;13:5449-5468. PMID: 30271140. PMC6149985.
  5. Bartel MJ, Tokar JL. Non-Lifting Colorectal Neoplasia – Shall We CAST It Away? Endoscopy. 2018;50(1):6-7. PMID: 29268294.
  6. Battistuzzi FU, Tao Q, Jones L, Tamura K, Kumar S. RelTime Relaxes the Strict Molecular Clock Throughout the Phylogeny. Genome Biol Evol. 2018;10(6):1631-1636. PMID: 29878203. PMC6022624. .
  7. Bevelacqua JJ, Mortazavi SMJ. Commentary Regarding “on-Orbit Sleep Problems of Astronauts and Countermeasures”. Mil Med Res. 2018;5(1):38. PMID: 30376883. PMC6208067.
  8. Chakraborty H, Mogurampelly S, Yadav VK, Waghmare UV, Klein ML. Phonons and Thermal Conducting Properties of Borocarbonitride (BCN) Nanosheets. Nanoscale. 2018;10(47):22148-22154. PMID: 30357208.
  9. Chauhan N, Bukovcan J, Boucher E, et al. Intra-Arterial Therasphere Yttrium-90 Glass Microspheres in the Treatment of Patients with Unresectable Hepatocellular Carcinoma: Protocol for the STOP-HCC Phase 3 Randomized Controlled Trial. Journal of Medical Internet Research. 2018;20(8):e11234. PMID: 30111528. PMC6115595.
  10. Chernoff J. How to Get and Keep Your Lab Funded. Mol Biol Cell. 2018;29(21):2519-2521. PMID: 30325287.
  11. Correa AF, Yankey H, Li T, et al. Renal Hilar Lesions: Biological Implications for Complex Partial Nephrectomy. Urology. 2018. PMID: 30296503.
  12. Cristescu R, Mogg R, Ayers M, et al. Pan-Tumor Genomic Biomarkers for PD-1 Checkpoint Blockade-Based Immunotherapy. Science. 2018;362(6411). PMID: 30309915.
  13. Crook JM, Zhang P, Pisansky TM, et al. A Prospective Phase Ii Trial of Trans-Perineal Ultrasound-Guided Brachytherapy for Locally Recurrent Prostate Cancer after External Beam Radiotherapy (NRG Oncology/RTOG -0526). Int J Radiat Oncol Biol Phys. 2018. PMID: 30312717.
  14. Denlinger CS, Sanft T, Baker KS, et al. Survivorship, Version 2.2018 Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network. 2018;16(10):1216-1247. PMID: 30323092.
  15. Doss M. Letter by Doss Regarding Article, “Exposure to Low-Dose Ionizing Radiation from Cardiac Procedures and Malignancy Risk in Adults with Congenital Heart Disease”. Circulation. 2018;138(13):1375-1376. PMID: 30354420.
  16. Dow M, Pyke RM, Tsui BY, et al. Integrative Genomic Analysis of Mouse and Human Hepatocellular Carcinoma. Proc Natl Acad Sci U S A. 2018;115(42):E9879-e9888. PMID: 30287485. PMC6196518.
  17. Falchook G, Coleman RL, Roszak A, et al. Alisertib in Combination with Weekly Paclitaxel in Patients with Advanced Breast Cancer or Recurrent Ovarian Cancer: A Randomized Clinical Trial. JAMA Oncol. 2018:e183773. PMID: 30347019.
  18. Feldman G, Kappes D, Mookerjee-Basu J, Freeman T, Fertala A, Parvizi J. Novel Mutation in Teneurin 3 Found to Co-Segregate in All Affecteds in a Multi-Generation Family with Developmental Dysplasia of the Hip. J Orthop Res. 2018. PMID: 30273960.
  19. Feofanov AV, Andreeva TV, Studitsky VM, Kirpichnikov MP. Reversibility of Structural Rearrangements in Mononucleosomes Induced by Ionic Strength. Moscow University Biological Sciences Bulletin. 2018;73(3):157-161.
  20. Gadgeel SM, Stevenson JP, Langer CJ, et al. Pembrolizumab and Platinum-Based Chemotherapy as First-Line Therapy for Advanced Non–Small-Cell Lung Cancer: Phase 1 Cohorts from the KEYNOTE-021 Study. Lung Cancer. 2018;125:273-281. PMID: 30429032.
  21. Ge Y, Borne E, Stewart S, et al. Simulations of the Regulatory Act Domain of Human Phenylalanine Hydroxylase Unveil Its Mechanism of Phenylalanine Binding. J Biol Chem. 2018. PMID: 30287685.
  22. Gershman B, Bukavina L, Chen Z, et al. The Association of Robot-Assisted Versus Pure Laparoscopic Radical Nephrectomy with Perioperative Outcomes and Hospital Costs. Eur Urol Focus. 2018. PMID: 30361146.
  23. Ghatalia P, Koenigsberg R, Pisarcik D, Handorf EA, Geynisman DM, Zibelman M. The Evolution of Clinical Trials in Renal Cell Carcinoma: A Status Report for 2013-2016 from the Clinicaltrials.Gov Website. Kidney Cancer. 2017;1(2):151-159. PMID: 30334017. PMC6179107.
  24. Ghatalia P, Rathmell WK. Systematic Review: Clearcode 34 – a Validated Prognostic Signature in Clear Cell Renal Cell Carcinoma (ccRCC). Kidney Cancer. 2018;2(1):23-29. PMID: 30320241. PMC6176730. NIHMS935715..
  25. Greco F, Autorino R, Altieri V, et al. Ischemia Techniques in Nephron-Sparing Surgery: A Systematic Review and Meta-Analysis of Surgical, Oncological, and Functional Outcomes. Eur Urol. 2018. PMID: 30327272.
  26. Haas NB, Uzzo RG. Perioperative Therapy in Renal Cell Carcinoma: What Do We Know, What Have We Learned, What’s Next? J Clin Oncol. 2018:Jco2018789131. PMID: 30372398. .
  27. Haifler M, Ristau BT, Higgins AM, et al. External Validation of Contact Surface Area as a Predictor of Postoperative Renal Function in Patients Undergoing Partial Nephrectomy. Journal of Urology. 2018;199(3):649-654. PMID: 28941921.
  28. Herman AB, Autieri MV. Cardiovascular Disease, Inflammation, and MRNA Stability. Aging (Albany NY). 2018;10(11):3046-3047. PMID: 30365397.
  29. Hota P, Dass C, Erkmen C, Donuru A, Kumaran M. Poststernotomy Complications: A Multimodal Review of Normal and Abnormal Postoperative Imaging Findings. AJR: Am J Roentgenol. 2018;211(6):1-12. PMID: 30300004.
  30. Johnson C, Drummer Ct, Virtue A, et al. Increased Expression of Resistin in MicroRNA-155-Deficient White Adipose Tissues May Be a Possible Driver of Metabolically Healthy Obesity Transition to Classical Obesity. Front Physiol. 2018;9:1297. PMID: 30369883. PMC6194169.
  31. Jung K, Park JC, Kang H, Brandes JC. Androgen Deprivation Therapy Is Associated with Decreased Second Primary Lung Cancer Risk in the United States Veterans with Prostate Cancer. Epidemiol Health. 2018;40:e2018040. PMID: 30121970. PMC6232654.
  32. Kalemkerian GP, Loo BW, Jr., Akerley W, et al. Nccn Guidelines Insights: Small Cell Lung Cancer, Version 2.2018. J Natl Compr Canc Netw. 2018;16(10):1171-1182. PMID: 30323087.
  33. Kasimova MA, Yazici AT, Yudin Y, et al. A Hypothetical Molecular Mechanism for Trpv1 Activation That Invokes Rotation of an S6 Asparagine. J Gen Physiol. 2018;150(11):1554-1566. PMID: 30333107. PMC6219692.
  34. Kaur A, Ecker BL, Douglass SM, et al. Remodeling of the Collagen Matrix in Aging Skin Promotes Melanoma Metastasis and Affects Immune Cell Motility. Cancer Discov. 2018. PMID: 30279173.
  35. Kozlova AL, Valieva ME, Maluchenko NV, Studitsky VM. [HMGB Proteins as DNA Chaperones That Modulate Chromatin Activity]. Mol Biol (Mosk). 2018;52(5):737-749. PMID: 30363049.
  36. Kupfer SS, Lubner S, Coronel E, et al. Adherence to Postresection Colorectal Cancer Surveillance at National Cancer Institute-Designated Comprehensive Cancer Centers. Cancer Med. 2018;7(11):5351-5358. PMID: 30338661. PMC6247039.
  37. Liao L, Liu ZZ, Langbein L, et al. Multiple Tumor Suppressors Regulate a HIF-Dependent Negative Feedback Loop via ISGF3 in Human Clear Cell Renal Cancer. Elife. 2018;7. PMID: 30355451. PMC6234029.
  38. Liu Z, Chen M, Xie LK, et al. CLCA4 Inhibits Cell Proliferation and Invasion of Hepatocellular Carcinoma by Suppressing Epithelial-Mesenchymal Transition via PI3K/AKT Signaling. Aging (Albany NY). 2018;10(10):2570-2584. PMID: 30312171. PMC6224236.
  39. Localio AR, Stack CB, Meibohm AR, et al. Inappropriate Statistical Analysis and Reporting in Medical Research: Perverse Incentives and Institutional Solutions. Ann Intern Med. 2018;169(8):577-578. PMID: 30304363.
  40. Mazor AM, Mateo AM, Demora L, et al. Breast Conservation Versus Mastectomy in Patients with T3 Breast Cancers (> 5 Cm): An Analysis of 37,268 Patients from the National Cancer Database. Breast Cancer Res Treat. 2018. PMID: 30343456.
  41. Mookerjee-Basu J, Hua X, Ge L, et al. Functional Conservation of a Developmental Switch in Mammals since the Jurassic Age. Mol Biol Evol. 2018. PMID: 30295892.
  42. Moore HCF, Unger JM, Phillips KA, et al. Final Analysis of the Prevention of Early Menopause Study (Poems)/Swog Intergroup S0230. J Natl Cancer Inst. 2018. PMID: 30371800.
  43. Myers RE, Stello B, Daskalakis C, et al. Decision Support and Navigation to Increase Colorectal Cancer Screening among Hispanic Patients. Cancer Epidemiol Biomarkers Prev. 2018. PMID: 30333221.
  44. Necchi A, Pond GR, Moschini M, et al. Development of a Prediction Tool for Exclusive Locoregional Recurrence after Radical Cystectomy in Patients with Muscle-Invasive Bladder Cancer. Clin Genitourin Cancer. 2018. PMID: 30292628.
  45. Nieborowska-Skorska M, Maifrede S, Ye M, et al. Non-Nad-Like Parp1 Inhibitor Enhanced Synthetic Lethal Effect of Nad-Like Parp Inhibitors against Brca1-Deficient Leukemia. Leuk Lymphoma. 2018:1-4. PMID: 30277116.
  46. O’Neil PT, Machen AJ, Thompson JA, et al. Constructing Kinetically Controlled Denaturation Isotherms of Folded Proteins Using Denaturant-Pulse Chaperonin Binding. Methods Mol Biol. 2019;1873:293-304. PMID: 30341618. PMC6196737. NIHMS972764.
  47. Patel RS, Wen KY, Aggarwal R. Demographic Pattern and Hospitalization Outcomes of Depression among 2.1 Million Americans with Four Major Cancers in the United States. Med Sci (Basel). 2018;6(4). PMID: 30355962.
  48. Putatunda R, Zhang Y, Li F, Yang XF, Barbe MF, Hu W. Adult Neurogenic Deficits in HIV-1 Tg26 Transgenic Mice. J Neuroinflammation. 2018;15(1):287. PMID: 30314515. PMC6182864.
  49. Qian F, Wang S, Mitchell J, et al. Height and Body Mass Index as Modifiers of Breast Cancer Risk in BRCA1/2 Mutation Carriers: A Mendelian Randomization Study. J Natl Cancer Inst. 2018. PMID: 30312457.
  50. Qumseya BJ, Bartel MJ, Gendy S, Bain P, Qumseya A, Wolfsen H. High Rate of over-Staging of Barrett’s Neoplasia with Endoscopic Ultrasound: Systemic Review and Meta-Analysis. Dig Liver Dis. 2018;50(5):438-445. PMID: 29573963.
  51. Reese JB, Sorice K, Lepore SJ, Daly MB, Tulsky JA, Beach MC. Patient-Clinician Communication About Sexual Health in Breast Cancer: A Mixed-Methods Analysis of Clinic Dialogue. Patient Educ Couns. 2018. PMID: 30314828.
  52. Rice SR, Molitoris JK, Vyfhuis MAL, et al. Lymph Node Size Predicts for Asymptomatic Brain Metastases in Patients with Non-Small-Cell Lung Cancer at Diagnosis. Clin Lung Cancer. 2018. PMID: 30337268.
  53. Ristau BT, Smaldone MC. Performance Measurement and Quality Improvement Initiatives for Bladder Cancer Care. Curr Urol Rep. 2018;19(12):100. PMID: 30357590.
  54. Roach M, Moughan J, Lawton CAF, et al. Sequence of Hormonal Therapy and Radiotherapy Field Size in Unfavourable, Localised Prostate Cancer (NRG/RTOG 9413): Long-Term Results of a Randomised, Phase 3 Trial. Lancet Oncol. 2018;19(11):1504-1515. PMID: 30316827.
  55. Russell Localio A, Stack CB, Meibohm AR, et al. Inappropriate Statistical Analysis and Reporting in Medical Research: Perverse Incentives and Institutional Solutions. Ann Intern Med. 2018;169(8):577-578. PMID: 30304363.
  56. Schwartz LA, Henry-Moss D, Egleston B, et al. Preventative Health and Risk Behaviors among Adolescent Girls with and without Family Histories of Breast Cancer. J Adolesc Health. 2018. PMID: 30301677.
  57. Sha X, Hoffman B, Liebermann DA. Loss of Gadd45b Accelerates BCR-ABL-Driven CML. Oncotarget. 2018;9(70):33360-33367. PMID: 30279966. PMC6161793.
  58. Shaytan AK, Xiao H, Armeev GA, et al. Structural Interpretation of DNA-Protein Hydroxyl-Radical Footprinting Experiments with High Resolution Using Hydroid. Nat Protoc. 2018;13(11):2535-2556. PMID: 30341436.
  59. Stinchcombe TE, Fan W, Schild SE, et al. A Pooled Analysis of Individual Patient Data from National Clinical Trials Network Clinical Trials of Concurrent Chemoradiotherapy for Limited-Stage Small Cell Lung Cancer in Elderly Patients Versus Younger Patients. Cancer. 2018. PMID: 30343497.
  60. Stout MC, Campbell PM. Raspecting the Oncogene: New Pathways to Therapeutic Advances. Biochem Pharmacol. 2018;158:217-228. PMID: 30352234.
  61. Su F, Myers VD, Knezevic T, et al. Bcl-2-Associated Athanogene 3 Protects the Heart from Ischemia/Reperfusion Injury. JCI Insight. 2016;1(19):e90931. PMID: 27882354. PMC5111510.
  62. Sun Z, Zheng L, Chen M, Klein ML, Paesani F, Wu X. Electron-Hole Theory of the Effect of Quantum Nuclei on the X-Ray Absorption Spectra of Liquid Water. Phys Rev Lett. 2018;121(13):137401. PMID: 30312094.
  63. Timmermans S, Yang A, Gardner M, et al. Does Patient-Centered Care Change Genital Surgery Decisions? The Strategic Use of Clinical Uncertainty in Disorders of Sex Development Clinics. J Health Soc Behav. 2018;59(4):22146518802460. PMID: 30303019.
  64. Twardowski PW, Tangen CM, Wu X, et al. Parallel (Randomized) Phase II Evaluation of Tivantinib (ARQ197) and Tivantinib in Combination with Erlotinib in Papillary Renal Cell Carcinoma: SWOG S1107. Kidney Cancer. 2017;1(2):123-132. PMID: 30334014. PMC6179121.
  65. Tyner JW, Tognon CE, Bottomly D, et al. Functional Genomic Landscape of Acute Myeloid Leukaemia. Nature. 2018;562(7728):526-531. PMID: 30333627. PMC6280667.
  66. Upshaw JN, O’Neill A, Carver JR, et al. Fluoropyrimidine Cardiotoxicity: Time for a Contemporaneous Appraisal. Clin Colorectal Cancer. 2018. PMID: 30348619.
  67. Wheeler DC, Jones RM, Schootman M, Nelson EJ. Explaining Variation in Elevated Blood Lead Levels among Children in Minnesota Using Neighborhood Socioeconomic Variables. Sci Total Environ. 2019;650(Pt 1):970-977. PMID: 30308871.
  68. Wiest DL. Gadd45 Stress Sensors in Suppression of Leukemia. Oncotarget. 2018;9(76):34191-34192. PMID: 30344933. PMC6188131.
  69. Zhang F, Tapera TM, Gou J. Application of a New Dietary Pattern Analysis Method in Nutritional Epidemiology. BMC Med Res Methodol. 2018;18(1):119. PMID: 30373530. PMC6206725.
  70. Zhang S, Taylor AK, Huang X, et al. Venous Thromboembolism Laboratory Testing (factor V Leiden and factor II C.*97G>A), 2018 Update: A Technical Standard of the American College of Medical Genetics and Genomics (ACMG). Genet Med. 2018. PMID: 30297698.

Staff Publications: August-September 2018

  1. Ackroyd SA, Brown J, Houck K, et al. A Preoperative Risk Score to Predict Red Blood Cell Transfusion in Patients Undergoing Hysterectomy for Ovarian Cancer. Am J Obstet Gynecol. 2018. PMID: 30240655.
  2. Bella R, Kaminski R, Mancuso P, et al. Removal of HIV DNA by CRISPR from Patient Blood Engrafts in Humanized Mice. Mol Ther Nucleic Acids. 2018;12:275-282. PMID: 30195766. PMC6011019.
  3. Berry K, Elder D, Kroger L. The Evolving Role of the Medical Radiation Safety Officer. Health Phys. 2018;115(5):628-636. PMID: 30260854.
  4. Bevelacqua JJ, Mortazavi SMJ. Commentary: Immune System Dysregulation During Spaceflight: Potential Countermeasures for Deep Space Exploration Missions. Front Immunol. 2018;9:2024. PMID: 30233600. PMC6131484.
  5. Bodor JN, Kasireddy V, Borghaei H. First-Line Therapies for Metastatic Lung Adenocarcinoma without a Driver Mutation. J Oncol Pract. 2018;14(9):529-535. PMID: 30205771.
  6. Borgmann H, Cooperberg M, Murphy D, et al. Online Professionalism-2018 Update of European Association of Urology (@Uroweb) Recommendations on the Appropriate Use of Social Media. Eur Urol. 2018. PMID: 30177286.
  7. Boumber Y. Tumor Mutational Burden (TMB) as a Biomarker of Response to Immunotherapy in Small Cell Lung Cancer. J Thorac Dis. 2018;10(8):4689-4693. PMID: 30233840. PMC6129910.
  8. Bryan MS, Argos M, Andrulis IL, et al. Germline Variation and Breast Cancer Incidence: A Gene-Based Association Study and Whole-Genome Prediction of Early-Onset Breast Cancer. Cancer Epidemiology Biomarkers & Prevention. 2018;27(9):1057-1064. PMID: 29898891 PMCID: PMC6125194.
  9. Bukavina L, Tilburt JC, Konety B, et al. Perceptions of Prostate MRI and Fusion Biopsy of Radiation Oncologists and Urologists for Patients Diagnosed with Prostate Cancer: Results from a National Survey. Eur Urol Focus. 2018. PMID: 30219709.
  10. Burton LJ, Hawsawi O, Loyd Q, et al. Association of Epithelial Mesenchymal Transition with Prostate and Breast Health Disparities. PLoS One. 2018;13(9):e0203855. PMID: 30199553. PMC6130866.
  11. Cheung JY, Gordon J, Wang J, et al. Mitochondrial Dysfunction in Human Immunodeficiency Virus-1 Transgenic Mouse Cardiac Myocytes. J Cell Physiol. 2018. PMID: 30256393.
  12. Doss M. Are We Approaching the End of the Lnt Model Era? J Nucl Med. 2018. PMID: 30262515.
  13. Doss M. Pediatric Computed Tomography Scans and Cancer Risk. JAMA Pediatr. 2018. PMID: 30193290.
  14. DuBay DA, Ivankova NV, Herby I, et al. A Quantitative Appraisal of African Americans’ Decisions to Become Registered Organ Donors at the Driver’s License Office. Clin Transplant. 2018:e13402. PMID: 30179271.
  15. Fakhry C, Nguyen-Tan PF, Lambert L, et al. In Regard to Bossi Et Al. Int J Radiat Oncol Biol Phys. 2018;102(3):669-670. PMID: 30238902. Letter.
  16. Flaig TW, Spiess PE, Agarwal N, et al. Nccn Guidelines Insights: Bladder Cancer, Version 5.2018. J Natl Compr Canc Netw. 2018;16(9):1041-1053. PMID: 30181416.
  17. Fragoso MF, Romualdo GR, Vanderveer LA, et al. Lyophilized Acai Pulp (Euterpe Oleracea Mart) Attenuates Colitis-Associated Colon Carcinogenesis While Its Main Anthocyanin Has the Potential to Affect the Motility of Colon Cancer Cells. Food Chem Toxicol. 2018;121:237-245. PMID: 30194994.
  18. Ghadimi-Moghadam A, Mortazavi SMJ, Hosseini-Moghadam A, et al. Does Exposure to Static Magnetic Fields Generated by Magnetic Resonance Imaging Scanners Raise Safety Problems for Personnel? Journal of Biomedical Physics and Engineering. 2018;8(3):333-336.
  19. Goel N, D’Souza JW, Ruth KJ, et al. The Utility of Preoperative Vascular Grading in Patients Undergoing Surgery First for Pancreatic Cancer: Does Radiologic Arterial or Venous Involvement Predict Pathologic Margin Status? J Oncol. 2018;2018:7675262. PMID: 30186324. PMC6110012.
  20. Hall MJ, Morris AM, Sun W. Precision Medicine Versus Population Medicine in Colon Cancer: From Prospects of Prevention, Adjuvant Chemotherapy, and Surveillance. Am Soc Clin Oncol Educ Book. 2018(38):220-230. PMID: 30231337.
  21. Handorf EA, Heckman CJ, Darlow S, Slifker M, Ritterband L. A Hierarchical Clustering Approach to Identify Repeated Enrollments in Web Survey Data. Plos One. 2018;13(9):e0204394. PMID: 30252908.
  22. Hedges SB, Tao Q, Walker M, Kumar S. Accurate Timetrees Require Accurate Calibrations. Proc Natl Acad Sci U S A. 2018. PMID: 30266795. Letter.
  23. Jin X, Daher SS, Lee M, Buttaro B, Andrade RB. Ribosome-Templated Azide-Alkyne Cycloadditions Using Resistant Bacteria as Reaction Vessels: In Cellulo Click Chemistry. ACS Med Chem Lett. 2018;9(9):907-911. PMID: 30258539. PMC6142060.
  24. Johnson M, Pennell NA, Borghaei H. “My Patient Was Diagnosed with Nontargetable Advanced Non-Small Cell Lung Cancer. What Now?” Diagnosis and Initial Treatment Options for Newly Diagnosed Patients with Advanced Nsclc. Am Soc Clin Oncol Educ Book. 2018(38):696-707. PMID: 30231362.
  25. Kishan AU, Wang X, Seiferheld W, et al. Association of Gleason Grade with Androgen Deprivation Therapy Duration and Survival Outcomes: A Systematic Review and Patient-Level Meta-Analysis. JAMA Oncology. 2018.
  26. Kondrashova O, Topp M, Nesic K, et al. Methylation of All BRCA1 Copies Predicts Response to the PARP Inhibitor Rucaparib in Ovarian Carcinoma. Nat Commun. 2018;9(1):3970. PMID: 30266954. PMC6162272.
  27. Lee M, Hu D, Bunney G, et al. Health Behavior Practice among Understudied Chinese and Filipino Americans with Cardiometabolic Diseases. Prev Med Rep. 2018;11:240-246. PMID: 30210996. PMC6129966.
  28. Mani S, Ghosh J, Lan Y, et al. Epigenetic Changes in Reterm Birth Placenta Suggest a Role for Adamts Genes in Spontaneous Preterm Birth. Hum Mol Genet. 2018. PMID: 30239759.
  29. Manne SL, Kashy DA, Kissane DW, Ozga M, Virtue SM, Heckman CJ. The Course and Predictors of Perceived Unsupportive Responses by Family and Friends among Women Newly Diagnosed with Gynecological Cancers. Transl Behav Med. 2018. PMID: 30189025.
  30. Martin JM, Goldstein LJ. Profile of Abemaciclib and Its Potential in the Treatment of Breast Cancer. Onco Targets Ther. 2018;11:5253-5259. PMID: 30214230. PMC6120573.
  31. Mitchell TC, Hamid O, Smith DC, et al. Epacadostat Plus Pembrolizumab in Patients with Advanced Solid Tumors: Phase I Results from a Multicenter, Open-Label Phase I/Ii Trial (Echo-202/Keynote-037). J Clin Oncol. 2018:Jco2018789602. PMID: 30265610.
  32. Moten AS, Zhao H, Wu H, Farma JM. Malignant Granular Cell Tumor: Clinical Features and Long-Term Survival. J Surg Oncol. 2018. PMID: 30196562.
  33. Nacson J, Krais JJ, Bernhardy AJ, et al. Brca1 Mutation-Specific Responses to 53bp1 Loss-Induced Homologous Recombination and Parp Inhibitor Resistance. Cell Rep. 2018;24(13):3513-3527.e3517. PMID: 30257212.
  34. Nicholas Bodor J, Kasireddy V, Borghaei H. First-Line Therapies for Metastatic Lung Adenocarcinoma without a Driver Mutation. Journal of Oncology Practice. 2018;14(9):529-535.
  35. Ogba N, Arwood NM, Bartlett NL, et al. Chimeric Antigen Receptor T-Cell Therapy. J Natl Compr Canc Netw. 2018;16(9):1092-1106. PMID: 30181421.
  36. Pakyz AL, Kohinke R, Opper P, Hohmann SF, Jones RM, Nadpara P. High-Risk Medication Use for Clostridium Difficile Infection among Hospitalized Patients with Cancer. Am J Infect Control. 2018. PMID: 30220616.
  37. Paliwal Y, Gendron TL, Jones RM, Moczygemba L, Nadpara PA, Slattum PW. A Qualitative Study to Understand over-the-Counter Medication Use and Decision-Making among Residents of Senior-Living Communities. Res Social Adm Pharm. 2018. PMID: 30253975.
  38. Radich JP, Deininger M, Abboud CN, et al. Chronic Myeloid Leukemia, Version 1.2019 Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network. 2018;16(9):1108-1135. PMID: 30181422.
  39. Riddle DL, Slover JD, Ang DC, et al. Opioid Use Prior to Knee Arthroplasty in Patients Who Catastrophize About Their Pain: Preoperative Data from a Multisite Randomized Clinical Trial. J Pain Res. 2018;11:1549-1557. PMID: 30174454. PMC6109658.
  40. Ristau BT, Handorf EA, Cahn DB, Kutikov A, Uzzo RG, Smaldone MC. Partial Nephrectomy Is Not Associated with an Overall Survival Advantage over Radical Nephrectomy in Elderly Patients with Stage I and Ii Renal Masses: An Analysis of the National Cancer Database. Cancer. 2018. PMID: 30207380.
  41. Roberts ME, Aynardi JT, Chu CS. Uterine Leiomyosarcoma: A Review of the Literature and Update on Management Options. Gynecol Oncol. 2018. PMID: 30244960.
  42. Rudolph MJ, Vance DJ, Kelow S, et al. Contribution of an Unusual Cdr2 Element of a Single Domain Antibody in Ricin Toxin Binding Affinity and Neutralizing Activity. Protein Eng Des Sel. 2018. PMID: 30265352.
  43. Singh T, Lee EH, Hartman TR, Ruiz-Whalen DM, O’Reilly AM. Opposing Action of Hedgehog and Insulin Signaling Balances Proliferation and Autophagy to Determine Follicle Stem Cell Lifespan. Dev Cell. 2018;46(6):720-734.e726. PMID: 30197240. PMC6159899. NIHMS1504158.
  44. Thenuwara AC, Cerkez EB, Shumlas SL, et al. Nickel Confined in the Interlayer Region of Birnessite: An Active Electrocatalyst for Water Oxidation. Angew Chem Int Ed Engl. 2016;55(35):10381-10385. PMID: 27151204.
  45. Tong CMC, Lucas J, Shah A, Foote C, Simhan J. Author Reply to Editorial Comment on “Novel Multimodal Analgesia Protocol Significantly Decreases Opioid Requirements in Inflatable Penile Prosthesis Patients”. Journal of Sexual Medicine. 2018;15(9):1364-1365. PMID: 30224023.
  46. Ward WH, Fluke LM, McEvoy CS, Fitch JL, Ricca RL. An Examination of Military General Surgeon Comfort with Complex Hepatopancreatobiliary Procedures. American Surgeon. 2018;84(8):E343-E345. PMID: 30185350.
  47. Wheeler DC, Jones RM, Schootman M, Nelson EJ. Explaining Variation in Elevated Blood Lead Levels among Children in Minnesota Using Neighborhood Socioeconomic Variables. Science of the Total Environment. 2019;650:970-977.
  48. Winkfield KM, Phillips JK, Joffe S, Halpern MT, Wollins DS, Moy B. Addressing Financial Barriers to Patient Participation in Clinical Trials: Asco Policy Statement. J Clin Oncol. 2018:Jco1801132. PMID: 30212297.
  49. Wu S, Luo Y, Viswanathan U, et al. Cpams Induce Assembly of Hbv Capsids with Altered Electrophoresis Mobility: Implications for Mechanism of Inhibiting Pgrna Packaging. Antiviral Res. 2018;159:1-12. PMID: 30201396.
  50. Zhang Y, Arango G, Li F, et al. Comprehensive Off-Target Analysis of Dcas9-Sam-Mediated Hiv Reactivation Via Long Noncoding Rna and Mrna Profiling. BMC Med Genomics. 2018;11(1):78. PMID: 30200981. PMC6131778.
  51. Zuniga SA, Lango MN. Effect of Rural and Urban Geography on Larynx Cancer Incidence and Survival. Laryngoscope. 2018;128(8):1874-1880. PMID: 29238975.

Staff Publications: July 2018

It’s been a busy month here at Talbot Library — literature searches, journal renewals, database renewals. In the spirit of better late than never, we give you the staff publications list for July 2018.

  1. Bartel MJ, Srivastava A, Pohl H. Response. Gastrointest Endosc. 2018;88(1):201. PMID: 29935617.
  2. Bartel MJ, Tokar JL. Non-Lifting Colorectal Neoplasia – Shall We Cast It Away? Endoscopy. 2018;50(1):6-7. PMID: 29268294.
  3. Benson AB, 3rd, Venook AP, Al-Hawary MM, et al. Anal Carcinoma, Version 2.2018, Nccn Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2018;16(7):852-871. PMID: 30006428.
  4. Benson AB, 3rd, Venook AP, Al-Hawary MM, et al. Rectal Cancer, Version 2.2018, Nccn Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2018;16(7):874-901. PMID: 30006429.
  5. Bleicher RJ. Timing and Delays in Breast Cancer Evaluation and Treatment. Ann Surg Oncol. 2018;25(10):2829-2838. PMID: 29968031. PMC6123282.
  6. Bretthauer M, Kalager M, Weinberg DS. From Colorectal Cancer Screening Guidelines to Headlines: Beware! Ann Intern Med. 2018;169(6):405-406. PMID: 29987330.
  7. Burger RA, Deng W, Makker V, et al. Phase Ii Evaluation of Dalantercept in the Treatment of Persistent or Recurrent Epithelial Ovarian Cancer: An Nrg Oncology/Gynecologic Oncology Group Study. Gynecol Oncol. 2018;150(3):466-470. PMID: 30041929.
  8. Chang WL, Jackson C, Riel S, et al. Differential Preventive Activity of Sulindac and Atorvastatin in Apc(+/Min-Fccc)Mice with or without Colorectal Adenomas. Gut. 2018;67(7):1290-1298. PMID: 29122850. PMC6031273.
  9. Dampier W, Sullivan NT, Mell JC, et al. Broad-Spectrum and Personalized Guide Rnas for Crispr/Cas9 Hiv-1 Therapeutics. AIDS Res Hum Retroviruses. 2018. PMID: 29968495.
  10. Demark-Wahnefried W, Schmitz KH, Alfano CM, et al. Weight Management and Physical Activity Throughout the Cancer Care Continuum. CA Cancer J Clin. 2018;68(1):64-89. PMID: 29165798. PMC5766382.
  11. Diefenbach MA, Benedict C, Miller SM, et al. Examining the Impact of a Multimedia Intervention on Treatment Decision-Making among Newly Diagnosed Prostate Cancer Patients: Results from a Nationwide Rct. Transl Behav Med. 2018. PMID: 29982747.
  12. Doss M. Radiation Dose from Cardiac Catheterization Procedures in Young Patients May Not Contribute to Increased Cancer Risk. Eur J Epidemiol. 2018;33(4):425-426. PMID: 29616389.
  13. Ettinger DS, Aisner DL, Wood DE, et al. Nccn Guidelines Insights: Non-Small Cell Lung Cancer, Version 5.2018. J Natl Compr Canc Netw. 2018;16(7):807-821. PMID: 30006423.
  14. Fareed MM, DeMora L, Esnaola NF, et al. Concurrent Chemoradiation for Resected Gall Bladder Cancers and Cholangiocarcinomas. J Gastrointest Oncol. 2018;9(4):762-768. PMID: 30151273. PMC6087856.
  15. Gangolli RA, Devlin SM, Gerstenhaber JA, Lelkes PI, Yang M. A Bilayered Poly (Lactic-Co-Glycolic Acid) Scaffold Provides Differential Cues for the Differentiation of Dental Pulp Stem Cells. Tissue Eng Part A. 2018. PMID: 29984629.
  16. Guo Y, Chu X, Parrott NJ, et al. Advancing Predictions of Tissue and Intracellular Drug Concentrations Using in Vitro, Imaging and Physiologically Based Pharmacokinetic Modeling Approaches. Clin Pharmacol Ther. 2018. PMID: 30059145.
  17. Gupta S, Kelow S, Wang L, Andrake MD, Dunbrack RL, Jr., Kruger WD. Mouse Modeling and Structural Analysis of the P.G307s Mutation in Human Cystathionine Beta-Synthase (Cbs) Reveal Effects on Cbs Activity but Not Stability. J Biol Chem. 2018;293(36):13921-13931. PMID: 30030379. PMC6130948.
  18. Gurova K, Chang HW, Valieva ME, Sandlesh P, Studitsky VM. Structure and Function of the Histone Chaperone Fact – Resolving Factual Issues. Biochim Biophys Acta Gene Regul Mech. 2018. PMID: 30055319.
  19. He P, Zhang BW, Arasteh S, Wang L, Abel R, Levy RM. Conformational Free Energy Changes Via an Alchemical Path without Reaction Coordinates. J Phys Chem Lett. 2018;9(15):4428-4435. PMID: 30024165. PMC6092130.
  20. Ingram JP, Tursi S, Zhang T, et al. A Nonpyroptotic Ifn-Gamma-Triggered Cell Death Mechanism in Nonphagocytic Cells Promotes Salmonella Clearance in Vivo. J Immunol. 2018;200(10):3626-3634. PMID: 29654208. PMC6034694.
  21. Jelinek J, Lee JT, Cesaroni M, et al. Digital Restriction Enzyme Analysis of Methylation (Dream). Methods Mol Biol. 2018;1708:247-265. PMID: 29224148.
  22. Kaminski R, Chen Y, Salkind J, et al. Negative Feedback Regulation of Hiv-1 by Gene Editing Strategy. Sci Rep. 2016;6:31527. PMID: 27528385. PMC4985742.
  23. Karakasheva TA, Lin EW, Tang Q, et al. Il-6 Mediates Cross-Talk between Tumor Cells and Activated Fibroblasts in the Tumor Microenvironment. Cancer Res. 2018;78(17):4957-4970. PMID: 29976575. PMC6125177.
  24. Kasireddy V, Martin J, Rubin RN. A 65-Year-Old Man with Cancer and a New Acute Dvt. Consultant. 2018;58(7):182-184.
  25. Khatri NV, Patel B, Kohli DR, Solomon SS, Bull-Henry K, Kessler CM. Lenalidomide as a Novel Therapy for Gastrointestinal Angiodysplasia in Von Willebrand Disease. Haemophilia. 2018;24(2):278-282. PMID: 29446520.
  26. Kim AH, Konety B, Chen Z, et al. Comparative Effectiveness of Local and Systemic Therapy for T4 Prostate Cancer. Urology. 2018. PMID: 29990574.
  27. Lee HO, Wang L, Kuo YM, Andrews AJ, Gupta S, Kruger WD. S-Adenosylhomocysteine Hydrolase over-Expression Does Not Alter S-Adenosylmethionine or S-Adenosylhomocysteine Levels in Cbs Deficient Mice. Mol Genet Metab Rep. 2018;15:15-21. PMID: 30023284. PMC6047060.
  28. Lee Z, Uzzo R, Asghar A, et al. Functional Parenchymal Volume-Based Spectrum Score Is Able to Quantify Ischemic Injury after Partial Nephrectomy. Urology. 2018. PMID: 30063909.
  29. Lheureux S, Butler MO, Clarke B, et al. Association of Ipilimumab with Safety and Antitumor Activity in Women with Metastatic or Recurrent Human Papillomavirus-Related Cervical Carcinoma. JAMA Oncol. 2018;4(7):e173776. PMID: 29145543. PMC6145732.
  30. Li Q, Damish A, Frazier ZJ, et al. Ercc2 Helicase Domain Mutations Confer Nucleotide Excision Repair Deficiency and Drive Cisplatin Sensitivity in Muscle-Invasive Bladder Cancer. Clin Cancer Res. 2018. PMID: 29980530.
  31. Lu Y, Beeghly-Fadiel A, Wu L, et al. A Transcriptome-Wide Association Study among 97,898 Women to Identify Candidate Susceptibility Genes for Epithelial Ovarian Cancer Risk. Cancer Res. 2018;78(18):5419-5430. PMID: 30054336. PMC6139053.
  32. Luo X, Jhala N, Khurana JS, Fundakowski C, Jhala DN, Wang H. Moving toward a Systematic Approach for Reporting Salivary Gland Cytopathology: An Institutional Experience and Literature Review. Arch Pathol Lab Med. 2018. PMID: 30044125.
  33. Lupey-Green LN, Caruso LB, Madzo J, et al. Parp1 Stabilizes Ctcf Binding and Chromatin Structure to Maintain Epstein-Barr Virus Latency Type. J Virol. 2018;92(18). PMID: 29976663. PMC6146685.
  34. Makhov P, Joshi S, Ghatalia P, Kutikov A, Uzzo RG, Kolenko VM. Resistance to Systemic Therapies in Clear Cell Renal Cell Carcinoma: Mechanisms and Management Strategies. Mol Cancer Ther. 2018;17(7):1355-1364. PMID: 29967214. PMC6034114. NIHMS967458.
  35. Merzianu M, Groman A, Hutson A, et al. Trends in Bone Marrow Sampling and Core Biopsy Specimen Adequacy in the United States and Canada: A Multicenter Study. Am J Clin Pathol. 2018;150(5):393-405. PMID: 30052721. PMC6166687.
  36. Miller KD, O’Neill A, Gradishar W, et al. Double-Blind Phase Iii Trial of Adjuvant Chemotherapy with and without Bevacizumab in Patients with Lymph Node-Positive and High-Risk Lymph Node-Negative Breast Cancer (E5103). J Clin Oncol. 2018;36(25):2621-2629. PMID: 30040523. PMC6118403.
  37. Moore KN, Bendell JC, LoRusso PM, et al. First-in-Human Study of the Anti-Hb-Egf Antibody U3-1565 in Subjects with Advanced Solid Tumors. Invest New Drugs. 2018. PMID: 30056611.
  38. Mortazavi SMJ, Rangacharyulu C, Bevelacqua JJ, Welsh J, Waligorski M, Doss M. Comments on “the Past Informs the Future: An Overview of the Million Worker Study and the Mallinckrodt Chemical Works Cohort”. Health Phys. 2018;115(3):387-388. PMID: 30045120.
  39. Nakagawa M, Shaffer AL, 3rd, Ceribelli M, et al. Targeting the Htlv-I-Regulated Batf3/Irf4 Transcriptional Network in Adult T Cell Leukemia/Lymphoma. Cancer Cell. 2018;34(2):286-297 e210. PMID: 30057145.
  40. Novosel E, Borchers K, Kluger PJ, et al. New Approaches to Respiratory Assist: Bioengineering an Ambulatory, Miniaturized Bioartificial Lung. Asaio j. 2018. PMID: 30044238.
  41. Pang M, Bartel MJ, Clayton DB, Brahmbhatt B, Woodward TA. Selective Application of Fully Covered Biliary Stents and Narrow-Diameter Esophageal Stents for Proximal Esophageal Indications. Endoscopy. 2018. PMID: 30005444.
  42. Ristau BT, Kutikov A. Editorial Comment. J Urol. 2018;199(3):639-640. PMID: 29227811.
  43. Ruggieri DG, Bass SB, Alhajji M, Gordon TF. Understanding Parents’ Perceptions of School-Based Bmi Screening and Bmi Report Cards Using Perceptual Mapping: Implications for School Nurses. J Sch Nurs. 2018:1059840518789243. PMID: 30033842.
  44. Scilla KA, Zandberg DP, Bentzen SM, et al. Case-Control Study of Pd-1, Pd-L1 and B7-H3 Expression in Lung Cancer Patients with and without Human Immunodeficiency Virus (Hiv) Infection. Lung Cancer. 2018;123:87-90. PMID: 30089601.
  45. Smith EP, Li H, Friedberg JW, et al. Tandem Autologous Hematopoietic Cell Transplantation for Patients with Primary Progressive or Recurrent Hodgkin Lymphoma: A Swog and Blood and Marrow Transplant Clinical Trials Network Phase Ii Trial (Swog S0410/Bmt Ctn 0703). Biol Blood Marrow Transplant. 2018;24(4):700-707. PMID: 29289757. PMC5965270.
  46. Sonpavde GP, Mariani L, LoVullo S, et al. Impact of the Number of Cycles of Platinum Based First Line Chemotherapy of Advanced Urothelial Carcinoma. J Urol. 2018. PMID: 30012366.
  47. Sparano J, O’Neill A, Alpaugh K, et al. Association of Circulating Tumor Cells with Late Recurrence of Estrogen Receptor-Positive Breast Cancer: A Secondary Analysis of a Randomized Clinical Trial. JAMA Oncol. 2018. PMID: 30054636.
  48. Stepanova DS, Braun L, Chernoff J. A New Concept in Nf2 Pharmacotherapy: Targeting Fatty Acid Synthesis. Oncoscience. 2018;5(5-6):126-127. PMID: 30035161. PMC6049319.
  49. Tan CRC, Barta SK, Lee J, Rudek MA, Sparano JA, Noy A. Combination Antiretroviral Therapy Accelerates Immune Recovery in Patients with Hiv-Related Lymphoma Treated with Epoch: A Comparison within One Prospective Trial Amc034. Leuk Lymphoma. 2018;59(8):1851-1860. PMID: 29160731. PMC5962410.
  50. Tong CMC, Lucas J, Shah A, Foote C, Simhan J. Novel Multi-Modal Analgesia Protocol Significantly Decreases Opioid Requirements in Inflatable Penile Prosthesis Patients. J Sex Med. 2018;15(8):1187-1194. PMID: 30017719.
  51. Wang Y, Yang E, Wells MM, et al. Propofol Inhibits the Voltage-Gated Sodium Channel Nachbac at Multiple Sites. J Gen Physiol. 2018;150(9):1317-1331. PMID: 30018039. PMC6122922.
  52. Ward WH, Goel N, Ruth KJ, et al. Predictive Value of Leukocyte- and Platelet-Derived Ratios in Rectal Adenocarcinoma. Journal of Surgical Research. 2018;232:275-282.
  53. Wei S, Ehya H. Degenerated Keratinized Tumor Cells in Oropharyngeal Human Papilloma Virus-Associated Squamous Cell Carcinoma: A Pitfall in P16 Immunostaining of Fine-Needle Aspiration Specimens. Acta Cytol. 2018:1-7. PMID: 29966127.
  54. Yang X, Yue R, Zhang J, et al. Gastrin Protects against Myocardial Ischemia/Reperfusion Injury Via Activation of Risk (Reperfusion Injury Salvage Kinase) and Safe (Survivor Activating Factor Enhancement) Pathways. J Am Heart Assoc. 2018;7(14). PMID: 30005556. PMC6064830.
  55. Zaorsky NG, Lehrer EJ, Handorf E, Meyer JE. Dose Escalation in Stereotactic Body Radiation Therapy for Pancreatic Cancer: A Meta-Analysis. Am J Clin Oncol. 2018. PMID: 29965809.
  56. Zhang B, Jiao A, Dai M, Wiest DL, Zhuang Y. Id3 Restricts Gammadelta Nkt Cell Expansion by Controlling Egr2 and C-Myc Activity. J Immunol. 2018;201(5):1452-1459. PMID: 30012846. PMC6103809.

Staff Publications: June 2018

  1. Bartel MJ, Srivastava A, Pohl H. Response. Gastrointest Endosc. 2018;88(1):201. PMID: 29935617.
  2. Battistuzzi FU, Tao Q, Jones L, Tamura K, Kumar S. Reltime Relaxes the Strict Molecular Clock Throughout the Phylogeny. Genome Biol Evol. 2018;10(6):1631-1636. PMID: 29878203. PMC6022624.
  3. Beatty A, Fink LS, Singh T, et al. Metabolite Profiling Reveals the Glutathione Biosynthetic Pathway as a Therapeutic Target in Triple-Negative Breast Cancer. Mol Cancer Ther. 2018;17(1):264-275. PMID: 29021292. PMC5892195.
  4. Beaufay C, Ledoux A, Jansen O, et al. In Vivo Antimalarial and Antitrypanosomal Activity of Strychnogucine B, a Bisindole Alkaloid from Strychnos Icaja. Planta Med. 2018;84(12-13):881-885. PMID: 29929205.
  5. Bichakjian CK, Olencki T, Aasi SZ, et al. Merkel Cell Carcinoma, Version 1.2018, Nccn Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2018;16(6):742-774. PMID: 29891526.
  6. Cagney DN, Martin AM, Catalano PJ, et al. Impact of Pemetrexed on Intracranial Disease Control and Radiation Necrosis in Patients with Brain Metastases from Non-Small Cell Lung Cancer Receiving Stereotactic Radiation. Radiother Oncol. 2018;126(3):511-518. PMID: 29398153.
  7. Cahn DB, Handorf EA, Smaldone MC. Bladder Extirpation Vs Preservation: The Treatment Debate. JAMA Surg. 2018. PMID: 29955758.
  8. Carqueijeiro I, Brown S, Chung K, et al. Two Tabersonine 6,7-Epoxidases Initiate Lochnericine-Derived Alkaloid Biosynthesis in Catharanthus Roseus. Plant Physiol. 2018;177(4):1473-1486. PMID: 29934299. PMC6084683.
  9. Chhatre S, Jefferson A, Cook R, et al. Patient-Centered Recruitment and Retention for a Randomized Controlled Study. Trials. 2018;19(1):205. PMID: 29587805. PMC5870194.
  10. Doss M. Letter by Doss Regarding Article, “Radiation-Induced DNA Damage in Operators Performing Endovascular Aortic Repair”. Circulation. 2018;137(24):2678-2679. PMID: 29891633.
  11. Drilon A, Laetsch TW, Kummar S, et al. Efficacy of Larotrectinib in Trk Fusion-Positive Cancers in Adults and Children. N Engl J Med. 2018;378(8):731-739. PMID: 29466156. PMC5857389.
  12. Engel N. Sex Differences in Early Embryogenesis: Inter-Chromosomal Regulation Sets the Stage for Sex-Biased Gene Networks: The Dialogue between the Sex Chromosomes and Autosomes Imposes Sexual Identity Soon after Fertilization. Bioessays. 2018;40(9):e1800073. PMID: 29943439.
  13. Ferris RL, Nikiforov Y, Terris D, et al. Ahns Series: Do You Know Your Guidelines? Ahns Endocrine Section Consensus Statement: State-of-the-Art Thyroid Surgical Recommendations in the Era of Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features. Head Neck. 2018;40(9):1881-1888. PMID: 29947030.
  14. Garriga J, Laumet G, Chen SR, et al. Nerve Injury-Induced Chronic Pain Is Associated with Persistent DNA Methylation Reprogramming in Dorsal Root Ganglion. J Neurosci. 2018;38(27):6090-6101. PMID: 29875269. PMC6031579.
  15. Goel N, Manstein SM, Ward WH, et al. Does the Surgical Apgar Score Predict Serious Complications after Elective Major Cancer Surgery? J Surg Res. 2018;231:242-247. PMID: 30278936.
  16. Golemis EA, Scheet P, Beck TN, et al. Molecular Mechanisms of the Preventable Causes of Cancer in the United States. Genes Dev. 2018;32(13-14):868-902. PMID: 29945886. PMC6075032.
  17. Good CR, Panjarian S, Kelly AD, et al. Tet1-Mediated Hypomethylation Activates Oncogenic Signaling in Triple-Negative Breast Cancer. Cancer Res. 2018;78(15):4126-4137. PMID: 29891505. PMC6072603.
  18. Haifler M, Ristau BT, Higgins AM, et al. External Validation of Contact Surface Area as a Predictor of Postoperative Renal Function in Patients Undergoing Partial Nephrectomy. J Urol. 2018;199(3):649-654. PMID: 28941921.
  19. Hayakawa K, Formica AM, Nakao Y, et al. Early Generated B-1-Derived B Cells Have the Capacity to Progress to Become Mantle Cell Lymphoma-Like Neoplasia in Aged Mice. J Immunol. 2018;201(2):804-813. PMID: 29898964. PMC6036230.
  20. Horwitz SM, Ansell SM, Ai WZ, et al. NCCN Guidelines Insights: T-Cell Lymphomas, Version 2.2018. J Natl Compr Canc Netw. 2018;16(2):123-135. PMID: 29439173.
  21. Janapati S, Wurtzel J, Dangelmaier C, et al. Tc21/Rras2 Regulates Glycoprotein Vi-Fcrgamma-Mediated Platelet Activation and Thrombus Stability. J Thromb Haemost. 2018. PMID: 29883056.
  22. Jordan SE, Micaily I, Hernandez E, et al. Image-Guided High-Dose-Rate Intracavitary Brachytherapy in the Treatment of Medically Inoperable Early-Stage Endometrioid Type Endometrial Adenocarcinoma. Brachytherapy. 2017;16(6):1144-1151. PMID: 28958736.
  23. Joshi SS, Handorf EA, Zibelman M, et al. Treatment Facility Volume and Survival in Patients with Metastatic Renal Cell Carcinoma: A Registry-Based Analysis. Eur Urol. 2018;74(3):387-393. PMID: 29880274.
  24. Kluetz PG, Kanapuru B, Lemery S, et al. Informing the Tolerability of Cancer Treatments Using Patient-Reported Outcome Measures: Summary of an Fda and Critical Path Institute Workshop. Value Health. 2018;21(6):742-747. PMID: 29909880.
  25. Kumar S, Konikoff C, Sanderford M, et al. Flyexpress 7: An Integrated Discovery Platform to Study Coexpressed Genes Using in Situ Hybridization Images in Drosophila. G3 (Bethesda). 2017;7(8):2791-2797. PMID: 28667017. PMC5555482.
  26. Lamb EP, Pritchard FE, Nouer SS, et al. Understanding Disparities in Breast Cancer Care in Memphis, Tennessee. Am Surg. 2018;84(5):620-627. PMID: 29966559.
  27. Lamb EP, Shaw FR, Fleming MD. Investigation of the Diagnostic Precision and Utility of Sentinel Lymph Node Biopsy in the Treatment of Patients with Merkel Cell Carcinoma. Am Surg. 2018;84(5):e173-175. PMID: 29966556.
  28. Lepore SJ, Collins BN, Coffman DL, et al. Kids Safe and Smokefree (Kiss) Multilevel Intervention to Reduce Child Tobacco Smoke Exposure: Long-Term Results of a Randomized Controlled Trial. Int J Environ Res Public Health. 2018;15(6). PMID: 29895740. PMC6025102.
  29. Lewis-Wambi JS, Kim HR, Wambi C, et al. Correction To: Buthionine Sulfoximine Sensitizes Antihormone-Resistant Human Breast Cancer Cells to Estrogen-Induced Apoptosis. Breast Cancer Res. 2018;20(1):57. PMID: 29903038. PMC6003045.
  30. Lim C, Cohn JR, Cohn JA. Can a Diagnosis of Bladder Cancer Motivate Positive Lifestyle Changes-and Prevent Recurrent Disease? Transl Androl Urol. 2018;7(Suppl 2):S242-S245. PMID: 29928624. PMC5989117.
  31. Lubner S, Feng Y, Mulcahy M, et al. E4206: Amg 706 and Octreotide in Patients with Low-Grade Neuroendocrine Tumors. Oncologist. 2018;23(9):1006-e1104. PMID: 29853660.
  32. Lukka HR, Pugh SL, Bruner DW, et al. Patient Reported Outcomes in Nrg Oncology Rtog 0938, Evaluating Two Ultrahypofractionated Regimens for Prostate Cancer. Int J Radiat Oncol Biol Phys. 2018;102(2):287-295. PMID: 29913254.
  33. Masselli E, Carubbi C, Cambo B, et al. The -2518 a/G Polymorphism of the Monocyte Chemoattractant Protein-1 as a Candidate Genetic Predisposition Factor for Secondary Myelofibrosis and Biomarker of Disease Severity. Leukemia. 2018;32(10):2266-2270. PMID: 29568096.
  34. Miura S, Gomez K, Murillo O, et al. Predicting Clone Genotypes from Tumor Bulk Sequencing of Multiple Samples. Bioinformatics. 2018. PMID: 29931046.
  35. Myers VD, McClung JM, Wang J, et al. The Multifunctional Protein Bag3: A Novel Therapeutic Target in Cardiovascular Disease. JACC Basic Transl Sci. 2018;3(1):122-131. PMID: 29938246. PMC6013050. NIHMS949382.
    36. Nguyen JL, Heckman C, Perna F. Analysis of the Twitter “Don’t Fry Day” Campaign. JAMA Dermatol. 2018;154(8):961-962. PMID: 29926080. PMC6143026.
  36. Podszywalow-Bartnicka P, Maifrede S, Le BV, Nieborowska-Skorska M, Piwocka K, Skorski T. PARP1 Inhibitor Eliminated Imatinib-Refractory Chronic Myeloid Leukemia Cells in Bone Marrow Microenvironment Conditions. Leuk Lymphoma. 2018:1-3. PMID: 29932782.
  37. Pourfarhangi KE, De La Hoz EC, Cohen AR, Gligorijevic B. Contact Guidance Is Cell Cycle-Dependent. APL Bioeng. 2018;2(3). PMID: 29911682. PMC5997297. NIHMS971860.
  38. Prudnikova TY, Chernoff J. The Group I Pak Inhibitor Frax-1036 Sensitizes 11q13-Amplified Ovarian Cancer Cells to the Cytotoxic Effects of Rottlerin. Small GTPases. 2017;8(4):193-198. PMID: 27427770. PMC5680705.
  39. Punglia RS, Jiang W, Lipsitz SR, et al. Clinical Risk Score to Predict Likelihood of Recurrence after Ductal Carcinoma in Situ Treated with Breast-Conserving Surgery. Breast Cancer Res Treat. 2018;167(3):751-759. PMID: 29079937.
  40. Ralff MD, El-Deiry WS. Trail Pathway Targeting Therapeutics. Expert Review of Precision Medicine and Drug Development. 2018;3(3):197-204.
  41. Reichert M, Bakir B, Moreira L, et al. Regulation of Epithelial Plasticity Determines Metastatic Organotropism in Pancreatic Cancer. Dev Cell. 2018;45(6):696-711 e698. PMID: 29920275. PMC6011231. NIHMS974111.
  42. Sandler KA, Cook RR, Ciezki JP, et al. Clinical Outcomes for Patients with Gleason Score 10 Prostate Adenocarcinoma: Results from a Multi-Institutional Consortium Study. Int J Radiat Oncol Biol Phys. 2018;101(4):883-888. PMID: 29976500.
  43. Scannell Bryan M, Argos M, Andrulis IL, et al. Germline Variation and Breast Cancer Incidence: A Gene-Based Association Study and Whole-Genome Prediction of Early-Onset Breast Cancer. Cancer Epidemiol Biomarkers Prev. 2018;27(9):1057-1064. PMID: 29898891. PMC6125194.
  44. Sementino E, Menges CW, Kadariya Y, et al. Inactivation of TP53 and PTEN Drives Rapid Development of Pleural and Peritoneal Malignant Mesotheliomas. J Cell Physiol. 2018;233(11):8952-8961. PMID: 29904909. PMC6168364.
  45. Shah MH, Goldner WS, Halfdanarson TR, et al. NCCN Guidelines Insights: Neuroendocrine and Adrenal Tumors, Version 2.2018. J Natl Compr Canc Netw. 2018;16(6):693-702. PMID: 29891520.
  46. Simons-Linares CR, Barkin JA, Wang Y, et al. Is There an Effect of Cannabis Consumption on Acute Pancreatitis? Dig Dis Sci. 2018. PMID: 29922897.
  47. Sullivan-Reed K, Bolton-Gillespie E, Dasgupta Y, et al. Simultaneous Targeting of Parp1 and Rad52 Triggers Dual Synthetic Lethality in Brca-Deficient Tumor Cells. Cell Rep. 2018;23(11):3127-3136. PMID: 29898385. PMC6082171.
  48. Tamura K, Tao Q, Kumar S. Theoretical Foundation of the RelTime Method for Estimating Divergence Times from Variable Evolutionary Rates. Mol Biol Evol. 2018;35(7):1770-1782. PMID: 29893954. PMC5995221.
  49. Virtue SM, Manne SL, Criswell K, Kissane D, Heckman CJ, Rotter D. Levels of Emotional Awareness During Psychotherapy among Gynecologic Cancer Patients. Palliat Support Care. 2018:1-8. PMID: 29880065.
  50. Wagner J, Kline CL, Zhou L, et al. Dose Intensification of Trail-Inducing ONC201 Inhibits Metastasis and Promotes Intratumoral NK Cell Recruitment. J Clin Invest. 2018;128(6):2325-2338. PMID: 29533922. PMC5983321.
  51. Walker EA. A Prospective Evaluation of Drug Discrimination in Pharmacology. Curr Top Behav Neurosci. 2018;39:319-328. PMID: 29959754.
  52. Warner WA, Lee TY, Fang F, et al. The Burden of Prostate Cancer in Trinidad and Tobago: One of the Highest Mortality Rates in the World. Cancer Causes Control. 2018;29(7):685-697. PMID: 29774450. PMC5999193.
  53. Winer A, Adams S, Mignatti P. Matrix Metalloproteinase Inhibitors in Cancer Therapy: Turning Past Failures into Future Successes. Mol Cancer Ther. 2018;17(6):1147-1155. PMID: 29735645. PMC5984693.
  54. Wong E, Xu RH, Rubio D, et al. Migratory Dendritic Cells, Group 1 Innate Lymphoid Cells, and Inflammatory Monocytes Collaborate to Recruit NK Cells to the Virus-Infected Lymph Node. Cell Rep. 2018;24(1):142-154. PMID: 29972776.
  55. Wu L, Shi W, Long J, et al. A Transcriptome-Wide Association Study of 229,000 Women Identifies New Candidate Susceptibility Genes for Breast Cancer. Nat Genet. 2018;50(7):968-978. PMID: 29915430.
  56. Xiao C, Moughan J, Movsas B, et al. Risk Factors for Late Bowel and Bladder Toxicities in NRG Oncology Prostate Cancer Trials of High-Risk Patients: A Meta-Analysis of Physician-Rated Toxicities. Adv Radiat Oncol. 2018;3(3):405-411. PMID: 30202809. PMC6128023.
  57. Zeng H, Nanayakkara GK, Shao Y, et al. DNA Checkpoint and Repair Factors Are Nuclear Sensors for Intracellular Organelle Stresses-Inflammations and Cancers Can Have High Genomic Risks. Front Physiol. 2018;9:516. PMID: 29867559. PMC5958474.
  58. Zhang D, Wang B, Zhang G, Ma C, Deng X. Comparison of 3d and 2d Gamma Passing Rate Criteria for Detection Sensitivity to IMRT Delivery Errors. J Appl Clin Med Phys. 2018;19(4):230-238. PMID: 29905004. PMC6036388.
  59. Zhang Y, Xiang J, Han Y, et al. Initial Experience of Robot-Assisted Ivor-Lewis Esophagectomy: 61 Consecutive Cases from a Single Chinese Institution. Dis Esophagus. 2018. PMID: 29873693.